ºÚÁϳԹÏÍø Associate Professor of Biopharmaceutical Sciences Dr. and Professor Dr. have been selected as 2021 recipients as part of the NIH Common Fund’s program. This fund supports inherently risky and untested projects that can potentially create or overturn fundamental science, technology, and medicine paradigms.
For the , the team is developing a computer assessment procedure for predicting the structure of antibodies that could effectively neutralize a previously unknown antigen or a novel virus that might emerge in the future. These findings could have a tremendous impact on any emerging pandemic.
In the podcast, Ray and Hernandez sit down to talk about the project and its implications for society.